المؤلفون: Damsky W; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut., King BA; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.

المصدر: JAMA dermatology [JAMA Dermatol] 2019 Mar 01; Vol. 155 (3), pp. 283-284.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Chilblains* , Lupus Erythematosus, Cutaneous*, Exodeoxyribonucleases/genetics ; Humans ; Janus Kinases ; Mutation

SCR Disease Name: Chilblain lupus 1

المؤلفون: Levine RM; Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut., Tattersall IW; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut., Gaudio PA; Department of Ophthalmology, Hartford Hospital, Hartford, Connecticut.; Connecticut Uveitis Foundation, West Hartford., King BA; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

المصدر: JAMA dermatology [JAMA Dermatol] 2018 Dec 01; Vol. 154 (12), pp. 1485-1486.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Algorithms*, Antibodies, Monoclonal/*therapeutic use , Blepharitis/*drug therapy , Cicatrix/*drug therapy , Conjunctivitis/*drug therapy, Antibodies, Monoclonal, Humanized ; Biopsy ; Blepharitis/complications ; Blepharitis/diagnosis ; Cicatrix/diagnosis ; Cicatrix/etiology ; Conjunctiva/pathology ; Conjunctivitis/complications ; Conjunctivitis/diagnosis ; Eyelids/pathology ; Follow-Up Studies ; Humans ; Male ; Middle Aged

المؤلفون: Kim SR; Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut., Heaton H; Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut., Liu LY; Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut., King BA; Department of Dermatology, Yale School of Medicine, Yale University, New Haven, Connecticut.

المصدر: JAMA dermatology [JAMA Dermatol] 2018 Mar 01; Vol. 154 (3), pp. 370-371.

نوع المنشور: Case Reports; Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Skin Pigmentation*/drug effects , Skin Pigmentation*/radiation effects , Ultraviolet Therapy*, Piperidines/*therapeutic use , Protein Kinase Inhibitors/*therapeutic use , Pyrimidines/*therapeutic use , Pyrroles/*therapeutic use , Vitiligo/*therapy, Adult ; Combined Modality Therapy ; Female ; Humans ; Male ; Middle Aged

المؤلفون: Dhayalan A; Albany Medical College, Albany, New York., King BA; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

المصدر: JAMA dermatology [JAMA Dermatol] 2016 Apr; Vol. 152 (4), pp. 492-3.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Alopecia/*complications , Nail Diseases/*drug therapy , Piperidines/*therapeutic use , Protein Kinase Inhibitors/*therapeutic use , Pyrimidines/*therapeutic use , Pyrroles/*therapeutic use, Adult ; Female ; Humans ; Janus Kinases/antagonists & inhibitors ; Male ; Nail Diseases/etiology ; Nail Diseases/pathology ; Nails

SCR Disease Name: Alopecia universalis

المؤلفون: Craiglow BG; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut., Tavares D; Quality Care Drug, Centerbrook, Connecticut., King BA; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

المصدر: JAMA dermatology [JAMA Dermatol] 2016 Apr; Vol. 152 (4), pp. 490-1.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Alopecia/*drug therapy , Janus Kinases/*antagonists & inhibitors , Protein Kinase Inhibitors/*administration & dosage , Pyrazoles/*administration & dosage, Administration, Topical ; Adolescent ; Female ; Humans ; Nitriles ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Pyrazoles/pharmacology ; Pyrazoles/therapeutic use ; Pyrimidines ; Treatment Outcome

SCR Disease Name: Alopecia universalis

المؤلفون: Craiglow BG; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut., King BA; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

المصدر: JAMA dermatology [JAMA Dermatol] 2015 Oct; Vol. 151 (10), pp. 1110-2.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Piperidines/*therapeutic use , Protein Kinase Inhibitors/*therapeutic use , Pyrimidines/*therapeutic use , Pyrroles/*therapeutic use , Skin Pigmentation/*drug effects , Vitiligo/*drug therapy, Administration, Oral ; Female ; Humans ; Janus Kinase 1/antagonists & inhibitors ; Janus Kinase 3/antagonists & inhibitors ; Middle Aged ; Piperidines/administration & dosage ; Piperidines/pharmacology ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/pharmacology ; Pyrimidines/administration & dosage ; Pyrimidines/pharmacology ; Pyrroles/administration & dosage ; Pyrroles/pharmacology ; Treatment Outcome ; Vitiligo/physiopathology